1.
Vaccine
; 9(8): 540-1, 1991 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-1663301
RESUMO
An inactivated hepatitis A virus (HAV) vaccine was tested on a group of human adult volunteers. The vaccine was administered subcutaneously, and a control group received a placebo (aluminium hydroxide). The vaccine was found to be relatively well tolerated and non-reactogenic, and levels of anti-HAV were comparable to those in other studies.